GREAT POINT PARTNERS LLC - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 59 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$35,250,348
+1.9%
3,078,633
-8.5%
6.42%
-5.2%
Q2 2023$34,578,713
+19.7%
3,363,688
-10.1%
6.77%
+19.4%
Q1 2023$28,878,675
+8.0%
3,740,761
+2.8%
5.67%
+8.2%
Q4 2022$26,737,227
+7.7%
3,637,718
+5.5%
5.24%
-12.3%
Q3 2022$24,829,000
+441.5%
3,448,521
+540.0%
5.98%
+443.5%
Q2 2022$4,585,000538,8191.10%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders